1. Canagliflozin in Asian patients with type 2 diabetes on metformin alone or metformin in combination with sulphonylurea. Issue 1 (14th October 2014) Authors: Ji, L.; Han, P.; Liu, Y.; Yang, G.; Dieu Van, N. K.; Vijapurkar, U.; Qiu, R.; Meininger, G. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 1(2015:Jan.) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus. Issue 4 (15th February 2015) Authors: Davies, M. J.; Trujillo, A.; Vijapurkar, U.; Damaraju, C. V.; Meininger, G. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 4(2015:Apr.) Page Start: 426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial. Issue 12 (13th October 2013) Authors: Wilding, J. P. H.; Charpentier, G.; Hollander, P.; González‐Gálvez, G.; Mathieu, C.; Vercruysse, F.; Usiskin, K.; Law, G.; Black, S.; Canovatchel, W.; Meininger, G. Journal: International journal of clinical practice Issue: Volume 67:Issue 12(2013) Page Start: 1267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease. Issue 5 (28th March 2013) Authors: Yale, J.‐F.; Bakris, G.; Cariou, B.; Yue, D.; David‐Neto, E.; Xi, L.; Figueroa, K.; Wajs, E.; Usiskin, K.; Meininger, G. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 5(2013:May) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise. Issue 4 (24th January 2013) Authors: Stenlöf, K.; Cefalu, W. T.; Kim, K.‐A.; Alba, M.; Usiskin, K.; Tong, C.; Canovatchel, W.; Meininger, G. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 4(2013:Apr.) Page Start: 372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease. Issue 10 (22nd July 2014) Authors: Yale, J.‐F.; Bakris, G.; Cariou, B.; Nieto, J.; David‐Neto, E.; Yue, D.; Wajs, E.; Figueroa, K.; Jiang, J.; Law, G.; Usiskin, K.; Meininger, G.; on behalf of the DIA3004 Study Group Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 10(2014:Oct.) Page Start: 1016 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone. Issue 5 (12th March 2014) Authors: Forst, T.; Guthrie, R.; Goldenberg, R.; Yee, J.; Vijapurkar, U.; Meininger, G.; Stein, P. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 5(2014:May) Page Start: 467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and safety of canagliflozin when used in conjunction with incretin‐mimetic therapy in patients with type 2 diabetes. Issue 1 (8th December 2015) Authors: Fulcher, G.; Matthews, D. R.; Perkovic, V.; de Zeeuw, D.; Mahaffey, K. W.; Mathieu, C.; Woo, V.; Wysham, C.; Capuano, G.; Desai, M.; Shaw, W.; Vercruysse, F.; Meininger, G.; Neal, B. Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 1(2016) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Glycaemic efficacy of canagliflozin is largely independent of baseline β‐cell function or insulin sensitivity. Issue 12 (15th November 2016) Authors: Matthews, D. R.; Zinman, B.; Tong, C.; Meininger, G.; Polidori, D. Journal: Diabetic medicine Issue: Volume 33:Issue 12(2016:Dec.) Page Start: 1744 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long‐term efficacy and safety of canagliflozin over 104 weeks in patients aged 55–80 years with type 2 diabetes. Issue 3 (12th January 2015) Authors: Bode, B.; Stenlöf, K.; Harris, S.; Sullivan, D.; Fung, A.; Usiskin, K.; Meininger, G. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 3(2015:Mar.) Page Start: 294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗